NASDAQ · AXG
Solowin financials
$0.1290−12.19%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 |
|---|---|
| Revenue | $28.0M |
| Gross profit | $28.0M |
| Gross margin | 100.0% |
| Operating income | -$13.0M |
| Net income | -$13.2M |
| Net margin | −47.0% |
| Diluted EPS | $-0.11 |
| EBITDA | -$12.9M |
| Operating cash flow | -$15.3M |
| Free cash flow | -$15.5M |
| Diluted shares | 124.9M |
Balance sheet
| Period end | Mar 31 |
|---|---|
| Cash & equivalents | $16.8M |
| Short-term investments | $0.00 |
| Total debt | $5.2M |
| Total assets | $50.7M |
| Total liabilities | $25.6M |
| Shareholders' equity | $25.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology